Bristol-Myers Squibb stock hits 52-week high at 62.89 USD
Bristol-Myers Squibb (BMY) stock reached a 52-week high, hitting 62.89 USD, marking a significant milestone for the company. The stock currently trades at 62.95 USD with a market capitalization of 127.94 billion USD.
Reported by 1 outlet — Investing.com · Company News. See all sources ↓
Bristol-Myers Squibb (BMY) stock reached a 52-week high, hitting 62.89 USD, marking a significant milestone for the company. The stock currently trades at 62.95 USD with a market capitalization of 127.94 billion USD. Over the past year, the stock has experienced a notable increase of 34.36%, with year-to-date gains of 19%. According to InvestingPro analysis, the stock appears overvalued relative to its Fair Value estimate, placing it among stocks on the most overvalued list.
Read the full report at Investing.com · Company News ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- Bristol-Myers Squibb (BMY) stock reached a 52-week high, hitting 62.89 USD, marking a significant milestone for the company. The stock currently trades at 62.95 USD with a market capitalization of 127.94 billion USD.
- How widely is it covered?
- 1 outlet, average source rating 5.0/10.
- When was it last updated?
- 9m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Bristol-Myers Squibb stock hits 52-week high at 62.89 USD
Sources1TypeCoverageInvesting.com · Company News